The process of obtaining a sample to measure lithium levels in the blood is a critical clinical procedure designed to ensure the therapeutic efficacy and safety of lithium treatment. Because lithium has a narrow therapeutic index, precise timing and specific collection protocols are mandatory to avoid misleading clinical decisions. The procedure involves the extraction of blood, which is then analyzed to determine the concentration of lithium, typically reported in mmol/L. This process can occur through traditional laboratory venous draws or via point-of-care testing, depending on the clinical urgency and availability of equipment. The primary objective of these collection protocols is to capture an accurate trough value, which is the lowest concentration of the drug in the patient's bloodstream, usually occurring shortly before the next scheduled dose.
Timing and Scheduling of Specimen Collection
The temporal aspect of lithium sample collection is the most critical variable in ensuring the accuracy of the results. Precise timing prevents the erroneous interpretation of lithium nonresponse and ensures that the dosing is correctly adjusted based on the patient's actual metabolic state.
The standard requirement for lithium testing is that it should take place 10 to 12 hours after the patient has taken their last dose of the medication. In many clinical settings, this means sample collection most often takes place in the morning, specifically before the patient takes their next dose of lithium. This ensures that the sample reflects the trough level.
However, dosing patterns can influence the recommended timing. For patients utilizing sustained-release preparations of lithium administered as a once-daily (OD) dose, research suggests that measuring at 24 hours may be recommended over the standard 12-hour window. This 24-hour measurement provides a more accurate trough value for those on a once-daily regimen, as opposed to the usual practice of measuring at 12 hours regardless of the dosing pattern.
The impact of incorrect timing is significant; failing to adhere to these windows can lead to misleading clinical decisions regarding the correct dose of lithium. This could potentially result in under-dosing, which leads to treatment failure, or over-dosing, which increases the risk of lithium toxicity.
Venous Blood Draw Procedures
The most common method for measuring lithium levels is through a venous blood draw, typically conducted in a medical office, a hospital, or a dedicated laboratory.
The procedural steps for a venous draw are as follows:
- The health professional begins by placing a tourniquet around the upper arm. This is done to increase the volume of blood in the vein, making the vein more prominent and easier to access.
- The area of the skin where the needle will be inserted is cleaned with an antiseptic wipe. This step is essential to prevent the introduction of external contaminants or infection into the bloodstream.
- A needle is then inserted into the vein to extract the required blood sample.
- Once the necessary volume of blood has been collected, the needle is removed from the vein.
- Pressure is applied to the puncture site using a piece of cotton or gauze. This action helps to stop any bleeding and reduces the likelihood of bruising at the site.
- A bandage is placed over the area to protect the site and maintain hygiene.
Patients may experience a slight sting or minor pain during the insertion and removal of the needle, but these sensations are brief. The risks associated with this procedure are very low, although light bruising or soreness in the arm may occur. Patients are advised to contact their physician if they experience severe pain or signs of infection following the draw.
Point-of-Care Testing (POCT)
Point-of-care testing serves as an alternative to traditional laboratory analysis, offering a faster method for monitoring lithium levels.
In POCT, a drop of blood is collected from the patient's fingertip rather than from a vein in the arm. This sample is then immediately analyzed using a small, specialized device. The primary advantage of this method is the speed of delivery; results are available within a few minutes, whereas laboratory results typically take several days.
Patients must consult with their healthcare provider to determine if point-of-care testing is available at their facility, as it is not a universal offering. This method is particularly useful in urgent clinical situations where immediate data is required to make dosing decisions.
Specimen Requirements and Laboratory Processing
The integrity of the lithium sample depends heavily on the type of collection tube used and the subsequent handling of the specimen.
Different laboratories may require different tube types. According to various specifications, the following tubes are acceptable:
- Plain red top tubes.
- Lavender top tubes containing K2EDTA.
- Pink top tubes containing K2EDTA.
- Light green top tubes containing lithium heparin.
For certain high-precision analyses, such as those conducted by ARUP, the serum or plasma must be separated from the cells as soon as possible, and certainly within 2 hours of collection. Once separated, 2 mL of the serum or plasma (with a minimum of 0.4 mL) should be transferred to an acid-washed transfer vial.
The following table outlines the technical specifications for specimen handling and volume:
| Specification | Requirement |
|---|---|
| Minimum Volume (RCH) | 1 mL |
| Minimum Volume (ARUP) | 0.4 mL |
| Specimen Type (RCH) | Blood: Serum - Gel |
| Stability (Ambient) | 2 weeks |
| Stability (Refrigerated) | 2 weeks |
| Stability (Frozen) | 1 year |
| Transport Temperature | 4 degrees Celsius |
The methodology used for quantitative analysis is Inductively Coupled Plasma-Mass Spectrometry (ICP-MS). This high-sensitivity method allows for the precise measurement of lithium concentrations in the serum or plasma.
Clinical Administration and Logistics
The management of lithium testing is a collaborative effort involving multiple health professionals.
Initially, lithium treatment is usually prescribed and monitored by a psychiatrist, who specializes in mental health conditions. Once a patient has reached a stable dose, the responsibility for monitoring may shift to other members of the healthcare team, such as a primary care provider or a mental health nurse.
Regarding the logistical aspects of the test:
- Facilities: Testing requires a visit to a laboratory, doctor's office, or hospital.
- Home Testing: There are currently no at-home test kits available for evaluating lithium levels in the blood.
- Costs: The cost varies based on health insurance coverage, laboratory fees, and the fee charged by the professional performing the blood draw. Patients are encouraged to discuss copays and deductibles with their insurance provider or facility administrator.
Urgent Specimen Handling
In cases where lithium testing is clinically urgent, specific protocols must be followed to ensure the sample is processed immediately.
If a test is urgent, the term "URGENT" must be clearly indicated on the request form. For samples received during business hours (Monday through Friday), the laboratory will process the specimen as an urgent send-away. If a specimen is received after hours, the laboratory staff must contact the requesting doctor to determine the urgency of the result. In specific regional protocols, such as at Melbourne Health Pathology, the Biochemistry department must be contacted via phone to advise of an urgent out-of-hours request before the sample is dispatched.
Result Reporting and Interpretation
The final stage of the collection process is the reporting and interpretation of the measured lithium levels.
For standard laboratory draws, results are typically available to the physician within a few days. These results may be delivered to the patient via an online medical portal, through the mail, or via a direct consultation with the doctor. In contrast, point-of-care testing provides results within minutes.
The test report provides the lithium level measured in mmol/L. This value is then compared against reference intervals to determine if the patient is within the therapeutic range, below the therapeutic threshold, or in a toxic range.
The following list summarizes the common aliases for lithium preparations associated with these tests:
- Eskalith
- Lithane
- Lithobid
Analysis of Collection Variables
The success of lithium sample collection is dependent on the intersection of patient compliance, phlebotomy precision, and laboratory stability. The transition from a 12-hour window to a 24-hour window for sustained-release medications represents a significant shift in clinical understanding, highlighting that "standard" timing is not universal. The use of ICP-MS methodology ensures that the concentration is measured with high accuracy, but this accuracy is void if the pre-analytical phase—specifically the separation of serum from cells within 2 hours—is neglected.
Furthermore, the logistical divide between POCT and central laboratory testing creates two different clinical pathways. POCT offers immediate feedback for acute management, while central labs provide a standardized, high-volume approach for long-term maintenance. The requirement for acid-washed vials in certain laboratory settings suggests a need to eliminate trace mineral interference, further emphasizing the high sensitivity of the lithium assay. Ultimately, the orchestration of timing, tube selection, and transport temperature (4 degrees Celsius) is what prevents erroneous interpretations of a patient's response to the medication.